What is the typical dose of oral amiodarone for treating arrhythmias?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Oral Amiodarone Dosing for Arrhythmias

For ventricular arrhythmias, start with an oral loading dose of 800-1,600 mg per day in divided doses until a cumulative total of 10 grams is reached, then reduce to a maintenance dose of 200-400 mg daily. 1, 2

Loading Dose Regimens by Arrhythmia Type

Ventricular Arrhythmias (VT/VF)

  • Inpatient loading: 800-1,600 mg per day in divided doses until 10 g total cumulative dose is achieved 1, 2
  • Outpatient loading: 600-800 mg per day in divided doses until 10 g total cumulative dose 3
  • Alternative regimen: 400-600 mg daily in divided doses for 2-4 weeks 2
  • The American Academy of Family Physicians supports the higher loading doses (800-1,600 mg/day) for ventricular arrhythmias given their life-threatening nature 1

Atrial Fibrillation

  • Inpatient loading: 1,200-1,800 mg per day in divided doses until 10 g total, then 200-400 mg daily maintenance 3
  • Outpatient loading: 600-800 mg per day in divided doses until 10 g total, then 200 mg daily maintenance 3, 2
  • The lower maintenance dose (200 mg) for atrial fibrillation reflects the less aggressive approach needed compared to ventricular arrhythmias 2

Transitioning from IV to Oral Therapy

The oral dose depends on the duration of prior IV therapy: 1, 2

  • IV therapy <1 week: Start 800-1,600 mg oral daily
  • IV therapy 1-3 weeks: Start 600-800 mg oral daily
  • IV therapy >3 weeks: Start 400 mg oral daily

This stepwise reduction accounts for amiodarone's extensive tissue accumulation during prolonged IV administration 1, 2

Maintenance Dosing Strategy

  • Standard maintenance: 200-400 mg daily after loading phase complete 3, 1, 2
  • Dose reduction is frequently necessary due to side effects—in one study, the mean dose decreased from 572 mg/day at 45 days to 372 mg/day at 6 months 4
  • Use the lowest effective maintenance dose to minimize toxicity, as adverse effects correlate directly with cumulative amiodarone exposure 1

Critical Monitoring Parameters

During Loading Phase

  • Watch for bradycardia, QT prolongation, hypotension, and heart block 2
  • The full antiarrhythmic effect may take days to weeks despite adequate serum levels due to amiodarone's extremely long half-life (14-58 days after chronic therapy) 2, 5
  • Gastrointestinal side effects (especially constipation) occur in the majority of patients 4

Long-Term Monitoring

  • Pulmonary toxicity is the most serious concern—presents as subacute cough and progressive dyspnea with interstitial infiltrates 1
  • Thyroid dysfunction, hepatic toxicity, and corneal microdeposits require ongoing surveillance 2, 4
  • In one series, 93% of patients developed side effects, with 19% requiring discontinuation 4

Common Pitfalls to Avoid

  • Do not use standard 600 mg daily maintenance doses routinely—this was associated with near-universal side effects in early studies, necessitating dose reductions 4
  • Do not expect immediate effect—amiodarone's onset is delayed compared to Class IC agents, with maximal effect often requiring weeks 3
  • Avoid in patients with structural heart disease requiring rapid cardioversion—Class IC drugs work faster for acute conversion, though amiodarone is safer in heart failure 3
  • Remember drug interactions—particularly with warfarin and digoxin, which require dose adjustments 2

References

Guideline

Amiodarone Dosage Guidelines for Stable Ventricular Tachycardia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Amiodarone Loading Dose Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias.

Journal of the American College of Cardiology, 1983

Research

Amiodarone: a unique antiarrhythmic agent.

Clinical pharmacy, 1983

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.